MetLife, Inc. (NYSE:MET) – Langen Mcalenn lowered their Q2 2017 earnings per share (EPS) estimates for shares of MetLife in a research note issued on Wednesday. Langen Mcalenn analyst L. Greenberg now expects that the financial services provider will post earnings per share of $1.29 for the quarter, down from their previous forecast of $1.30. Langen Mcalenn also issued estimates for MetLife’s Q4 2017 earnings at $1.38 EPS.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, May 3rd. The financial services provider reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.19. The business had revenue of $16.27 billion for the quarter, compared to analysts’ expectations of $17.02 billion. MetLife had a negative net margin of 0.95% and a positive return on equity of 7.57%. The firm’s quarterly revenue was down 11.7% compared to the same quarter last year. During the same period last year, the firm posted $1.20 earnings per share.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/07/21/metlife-inc-to-post-q2-2017-earnings-of-1-29-per-share-langen-mcalenn-forecasts-nysemet.html.

Several other analysts have also recently issued reports on the stock. Wells Fargo & Company reiterated an “outperform” rating and issued a $63.00 target price (up from $61.00) on shares of MetLife in a research note on Wednesday, July 12th. Royal Bank Of Canada reiterated a “buy” rating and issued a $62.00 target price on shares of MetLife in a research note on Wednesday, July 12th. Citigroup Inc. set a $51.00 price target on shares of MetLife and gave the stock a “sell” rating in a report on Friday, July 7th. BidaskClub raised shares of MetLife from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Finally, ValuEngine raised shares of MetLife from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, six have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $57.03.

MetLife (NYSE:MET) opened at 54.58 on Friday. The company’s market capitalization is $58.72 billion. The company has a 50-day moving average of $53.79 and a 200-day moving average of $53.02. MetLife has a 52 week low of $38.87 and a 52 week high of $58.09.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be issued a $0.40 dividend. The ex-dividend date is Thursday, August 3rd. This represents a $1.60 annualized dividend and a yield of 2.93%. MetLife’s dividend payout ratio (DPR) is presently -258.06%.

A number of hedge funds and other institutional investors have recently modified their holdings of MET. BlackRock Inc. raised its stake in shares of MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock worth $3,616,895,000 after buying an additional 66,475,603 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock worth $3,452,559,000 after buying an additional 1,885,246 shares in the last quarter. State Street Corp raised its stake in shares of MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock worth $2,589,297,000 after buying an additional 680,903 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock worth $541,427,000 after buying an additional 664,918 shares in the last quarter. Finally, Morgan Stanley raised its stake in shares of MetLife by 5.4% in the first quarter. Morgan Stanley now owns 7,946,397 shares of the financial services provider’s stock worth $419,728,000 after buying an additional 404,104 shares in the last quarter. 74.51% of the stock is owned by institutional investors and hedge funds.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Earnings History and Estimates for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.